The Global Fabry Disease Treatment Market Size is Expected to Grow from USD 2.50 Billion in 2023 to USD 6.30 Billion by 2033, at a CAGR of 7.86% during the forecast period 2023-2033. The Fabry disease treatment market is the worldwide market engaged in developing, manufacturing, and marketing therapies for Fabry disease, a genetic disease with low incidence caused by an insufficiency of the alpha-galactosidase A (GLA) enzyme.